BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30842110)

  • 1. Measuring 21 low-value hospital procedures: claims analysis of Australian private health insurance data (2010-2014).
    Chalmers K; Pearson SA; Badgery-Parker T; Brett J; Scott IA; Elshaug AG
    BMJ Open; 2019 Mar; 9(3):e024142. PubMed ID: 30842110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the high users of hospital resources: implications of a profile developed from Australian health insurance claims data.
    Khoo J; Hasan H; Eagar K
    Aust Health Rev; 2018 Sep; 42(5):600-606. PubMed ID: 29127955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilisation patterns of privately funded mental health services in Australia.
    Khoo J; Hasan H; Eagar K
    J Health Organ Manag; 2019 Mar; 33(1):5-17. PubMed ID: 30859910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of private insurance incentive policy reforms on trends in coronary revascularisation procedures in the private and public health sectors in Western Australia: a cohort study.
    Trafalski S; Briffa T; Hung J; Moorin RE; Sanfilippo F; Preen DB; Einarsdóttir K
    BMC Health Serv Res; 2013 Jul; 13():280. PubMed ID: 23870450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private versus public? Examining hospital use by a privately insured population in New South Wales, Australia, using data linkage.
    Khoo J; Hasan H; Eagar K
    Aust Health Rev; 2021 Feb; 45(1):14-21. PubMed ID: 33012306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Introducing Public Funding for Allied Health Psychotherapy Lead to Reductions in Private Insurance Claims? Lessons for Canada from the Australian Experience.
    Diminic S; Bartram M
    Can J Psychiatry; 2019 Jan; 64(1):68-76. PubMed ID: 29925270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of Low-Value Service in Australian Public Hospitals and the Association With Patient Insurance Status.
    de Oliveira Costa J; Pearson SA; Elshaug AG; van Gool K; Jorm LR; Falster MO
    JAMA Netw Open; 2021 Dec; 4(12):e2138543. PubMed ID: 34889943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First steps towards price transparency: comparability of online out-of-pocket tools from Australian private health funds.
    Chalmers K; Elshaug AG; Larkin S
    Aust Health Rev; 2020 Jun; 44(3):347-354. PubMed ID: 31715123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Population-Based Disease Management Services on Health Care Utilisation and Costs: Results of the CAPICHe Trial.
    Scuffham PA; Byrnes JM; Pollicino C; Cross D; Goldstein S; Ng SK
    J Gen Intern Med; 2019 Jan; 34(1):41-48. PubMed ID: 30264259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has inpatient hospital treatment before and after age 65 changed as the difference between private and Medicare payment rates has widened?
    Selden TM; Karaca Z; Decker S
    Int J Health Econ Manag; 2018 Dec; 18(4):409-423. PubMed ID: 29696508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting to outpatient care? Mental health care use and cost under private insurance.
    Leslie DL; Rosenheck R
    Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Payer Type and Low-Value Care: Comparing Choosing Wisely Services across Commercial and Medicare Populations.
    Colla CH; Morden NE; Sequist TD; Mainor AJ; Li Z; Rosenthal MB
    Health Serv Res; 2018 Apr; 53(2):730-746. PubMed ID: 28217968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of private funding on access to elective hospital treatment in the regions of England and Wales. National records survey.
    Williams B; Whatmough P; McGill J; Rushton L
    Eur J Public Health; 2001 Dec; 11(4):402-6. PubMed ID: 11766481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of the Australian private health insurance sector in providing chronic disease management programs: current activities, challenges and constraints.
    Khoo J; Hasan H; Eagar K
    Aust Health Rev; 2019 Oct; 43(5):572-577. PubMed ID: 30857589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of private health insurance on waiting time in public hospitals.
    Yang O; Yong J; Zhang Y
    Health Econ; 2024 Jun; 33(6):1192-1210. PubMed ID: 38356048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
    Kurtz SM; Lau E; Ong KL; Katz JN; Bozic KJ
    Clin Orthop Relat Res; 2016 May; 474(5):1090-8. PubMed ID: 26683036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance status of patients admitted to specialty cardiac and competing general hospitals: are accusations of cherry picking justified?
    Cram P; Pham HH; Bayman L; Vaughan-Sarrazin MS
    Med Care; 2008 May; 46(5):467-75. PubMed ID: 18438194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflections on the role of less-than-comprehensive (exclusionary) private health insurance hospital products in the Australian healthcare system.
    Thomas PE
    Aust Health Rev; 2012 Aug; 36(3):273-6. PubMed ID: 22935116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the increase in private health insurance uptake affected the Victorian public hospital surgical waiting list?
    Hanning B
    Aust Health Rev; 2002; 25(6):64-71. PubMed ID: 12536864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.